ID   EPG85-257RDB
AC   CVCL_X175
SY   EPG85-257-RDB; EPG85-257/RDB; EPG85-257RDB/K3; EPG85-257P-RDB; 257RD
DR   Wikidata; Q54832366
RX   PubMed=10949126;
RX   PubMed=15812352;
RX   PubMed=15875780;
CC   Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X333 ! EPG85-257P
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 9
//
RX   PubMed=10949126; DOI=10.1080/02656730050074069;
RA   Lage H., Jordan A.G., Scholz R., Dietel M.;
RT   "Thermosensitivity of multidrug-resistant human gastric and pancreatic
RT   carcinoma cells.";
RL   Int. J. Hyperthermia 16:291-303(2000).
//
RX   PubMed=15812352;
RA   Jordan A.G., Scholz R.;
RT   "Selection and characterization of heat-resistant variants of
RT   multidrug-resistant human gastric carcinoma cell lines.";
RL   Exp. Oncol. 27:18-23(2005).
//
RX   PubMed=15875780;
RA   Heim S., Lage H.;
RT   "Transcriptome analysis of different multidrug-resistant gastric
RT   carcinoma cells.";
RL   In Vivo 19:583-590(2005).
//